Sherman Mark Andrew's Form 4 filing
Dolby Laboratories, Inc. (DLB) · filed Feb 9, 2022
- Accession no.
- 0001209191-22-008259
- Filed
- Feb 9, 2022
- Trade date
- Feb 9, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $138.9K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sherman Mark AndrewCIK 0001256708 | Officer (EVP, GEN. COUN. & SECRTY) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2022 | Class A Common Stock | SSaleDisposed | −1,798 | $77.23 | −$138,859.54 | 51,601 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.